BrightSpring Health Services, Inc. (NASDAQ:BTSG) Shares Purchased by Northern Trust Corp

Northern Trust Corp lifted its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 12.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 535,334 shares of the company’s stock after purchasing an additional 60,111 shares during the period. Northern Trust Corp’s holdings in BrightSpring Health Services were worth $9,117,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in BTSG. Rhumbline Advisers raised its position in BrightSpring Health Services by 1.5% during the fourth quarter. Rhumbline Advisers now owns 73,583 shares of the company’s stock worth $1,253,000 after acquiring an additional 1,118 shares during the last quarter. MetLife Investment Management LLC raised its position in BrightSpring Health Services by 4.9% during the fourth quarter. MetLife Investment Management LLC now owns 33,117 shares of the company’s stock worth $564,000 after acquiring an additional 1,548 shares during the last quarter. Quarry LP acquired a new position in BrightSpring Health Services during the fourth quarter worth about $29,000. Legal & General Group Plc grew its holdings in shares of BrightSpring Health Services by 4.8% during the fourth quarter. Legal & General Group Plc now owns 64,631 shares of the company’s stock worth $1,101,000 after buying an additional 2,945 shares in the last quarter. Finally, R Squared Ltd purchased a new stake in shares of BrightSpring Health Services during the fourth quarter worth about $74,000.

BrightSpring Health Services Stock Performance

Shares of BTSG stock opened at $24.43 on Monday. BrightSpring Health Services, Inc. has a one year low of $10.15 and a one year high of $24.82. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. The company has a 50 day moving average price of $18.59 and a 200 day moving average price of $19.02. The firm has a market capitalization of $4.26 billion, a price-to-earnings ratio of -93.96 and a beta of 2.06.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings data on Friday, May 2nd. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.10. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The company had revenue of $2.88 billion during the quarter, compared to the consensus estimate of $2.74 billion. During the same period in the previous year, the firm earned $0.12 earnings per share. BrightSpring Health Services’s revenue for the quarter was up 25.9% on a year-over-year basis. Sell-side analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on BTSG. Morgan Stanley lifted their price target on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Mizuho set a $26.00 price target on shares of BrightSpring Health Services in a report on Monday, May 5th. Wells Fargo & Company lifted their price target on shares of BrightSpring Health Services from $25.00 to $27.00 and gave the stock an “overweight” rating in a report on Tuesday, May 13th. Finally, UBS Group lifted their price target on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, BrightSpring Health Services currently has an average rating of “Moderate Buy” and a consensus target price of $23.56.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.